eCOAs -- Driving Patient Engagement and Ensuring Data Continuity in the World of COVID-19

eCOAs -- Driving Patient Engagement and Ensuring Data Continuity in the World of COVID-19

  • December 2020 •
  • 5 pages •
  • Report ID: 6001637 •
  • Format: PDF
This IDC Perspective provides analyst insights on the growing importance of eCOAs, especially in the post-COVID-19 world. Despite the world being hit by a horrific pandemic, the pharma and biotech industry has risen to the occasion and leveraged digital transformation to bring trials to patients' homes. eCOAs drive "patient centric" clinical outcomes, and eCOA vendors continue to leverage technology to garner real-world insights into what matters most to the patient. "eCOAs have served as key enablers in incorporating the patients' voice in drug development and are an integral part of the digital strategy in reducing patient burden and driving continued patient engagement," said Dr. Nimita Limaye, research VP, Life Sciences R&D Strategy and Technology at IDC.